C32H48N4O8.HCl
Neat
616.76 36.46
alvespimycin; 467214-20-6; 17-DMAG; Alvespimycin [INN]; alvespimicina; alvespimycine; 17-dimethylaminoethylamino-17-demethoxygeldanamycin; UNII-001L2FE0M3; CHEBI:65324; 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin; NSC707545; [(4E, 6Z, 8S, 9S, 10E, 12S, 13R, 14S, 16R)-19-[2-(dimethylamino)ethylamino]-13-hydroxy-8, 14-dimethoxy-4, 10, 12, 16-tetramethyl-3, 20, 22-trioxo-2-azabicyclo[16.3.1]docosa-1(21), 4, 6, 10, 18-pentaen-9-yl] carbamate; NSC-707545; ALVESPIMYCIN [WHO-DD]; 17-DESMETHOXY-17-N, N-DIMETHYLAMINOETHYLAMINO-GELDANAMYCIN; (4E, 6Z, 8S, 9S, 10E, 12S, 13R, 14S, 16R)-19-{[2-(dimethylamino)ethyl]amino}-13-hydroxy-8, 14-dimethoxy-4, 10, 12, 16-tetramethyl-3, 20, 22-trioxo-2-azabicyclo[16.3.1]docosa-1(21), 4, 6, 10, 18-pentaen-9-yl carbamate; 17-dimethylaminoethylamino-17-demethoxy-geldanamycin; 17-(dimethylaminoethylamino)-17-demethoxy-geldanamycin; GELDANAMYCIN, 17-DEMETHOXY-17-((2-(DIMETHYLAMINO)ETHYL)AMINO)-; (4E, 6Z, 8S, 9S, 10E, 12S, 13R, 14S, 16R)-19-((2-(DIMETHYLAMINO)ETHYL)AMINO)-13-HYDROXY-8, 14-DIMETHOXY-4, 10, 12, 16-TETRAMETHYL-3, 20, 22-TRIOXO-2-AZABICYCLO(16.3.1)DOCOSA-1(21), 4, 6, 10 and 18-PENTAEN-9-YL CARBAMATE
[(4E, 6Z, 8S, 9S, 10E, 12S, 13R, 14S, 16R)-19-[2-(dimethylamino)ethylamino]-13-hydroxy-8, 14-dimethoxy-4, 10, 12, 16-tetramethyl-3, 20, 22-trioxo-2-azabicyclo[16.3.1]docosa-1(21), 4, 6, 10 and 18-pentaen-9-yl] carbamate
InChI=1S/C32H48N4O8/c1-18-14-22-27(34-12-13-36(5)6)24(37)17-23(29(22)39)35-31(40)19(2)10-9-11-25(42-7)30(44-32(33)41)21(4)16-20(3)28(38)26(15-18)43-8/h9-11,16-18,20,25-26,28,30,34,38H,12-15H2,1-8H3,(H2,33,41)(H,35,40)/b11-9-,19-10+,21-16+/t18-,20+,25+,26+,28-,30+/m1/s1